“Computational Modeling of Clinically Approved Alkylating Agents Against Epidermal and Fibroblast Growth Factor Receptors: A Step Toward Liver Cancer Therapeutics”, Pjmcr, vol. 4, no. 4, pp. 1970–1987, Dec. 2025, doi: 10.64105/d0gq9a09.